Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.33−0.19 (-12.76%)
Close on Nov 18, 2026Market cap $21.75MP/E –Yield –
Cellyan Biotechnology r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Cellyan Biotechnology
Cellyan Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?